Angelman alliance seeking research grant applications until June 30

Applicants can apply for up to €120K, with maximum grant duration of 4 years

Marisa Wexler, MS avatar

by Marisa Wexler, MS |

Share this article:

Share article via email
A hand holds up a coin amid dollar signs and packets of money in this grant funding illustration.

The Angelman Syndrome Alliance (ASA) is currently accepting grant applications from scientists who are doing basic research to enhance understanding of Angelman syndrome and possibly pave the way toward future treatments.

“Researchers of any country are invited to apply for research grants covering ‘basic science’ research that can help support a better understanding of Angelman Syndrome and eventually lead to new treatments tackling the genetic [and] molecular processes underlying the condition,” the Netherlands-based alliance stated in its call for grants.

Applications are being accepted through the end of June. Applicants can apply for up to €120,000 (about $130,000), and grant duration is flexible with a maximum of four years.

Recommended Reading
banner image for

Research Participation Is the Best Gift for Angelman Families

Grant seekers can apply on ASA’s website

The grant must include detailed descriptions of the planned scientific project, including a review of what’s already known, exact plans for experiments to be conducted, and discussions of the specific goals and expected significance. Applicants must include a curriculum vitae and details of a planned budget.

Full application instructions and registration to submit a grant are available on ASA’s website. The site also provides contacts that applicants can reach out to with questions about the grant application process or about doing research in Angelman syndrome.

Applicants who are selected to receive funding will be notified at the start of 2024, and the grant funding period will begin that April. Those selected are required to produce detailed reports on their findings for the ASA both midway through the project and once the project is over, and also must present results at ASA’s biannual conferences.

Angelman syndrome is a rare neurological disorder that’s caused by genetic mutations in the gene UBE3A. It’s characterized by symptoms like slowed development, lack of speech capabilities, difficulties with coordination, problems sleeping, and seizures.

The ASA is nonprofit organization that helps support scientific research on Angelman syndrome with the ultimate goal of improving care for patients. The international alliance works to pool the resources of smaller, local charities, bringing the community together to have a bigger impact. Currently, the alliance includes more than a dozen organizations in countries across Europe, as well as Israel and Japan.